Designed proteins assemble antibodies into modular
nanocages

16th April 2021by admin0

In a new report now published on Science, Robby Divine
and an interdisciplinary research team at the department of
biochemistry, regenerative medicine, and vaccines and infectious
disease at the University of Washington U.S. and the School of
Medicine, at the Tehran University of Medical Sciences, Iran,
conducted computational designs of nanocages to assemble antibodies
into precise architectures. During the construction, one structural
component formed an antibody or Fc-ligand fusion and the second
design formed an antibody-binding homo-oligomer to drive nanocage
assembly with different valencies and symmetry. The team
hypothesize how this process can also increase the neutralization
of a pseudovirus; severe acute respiratory syndrome coronavirus-2
(SARS-COV-2) via α- SARS-COV-2 monoclonal antibodies and
Fc-angiotensin-converting enzyme 2 (ACE-2) fusion
proteins.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright ©2024 New Fusion All Rights Reserved

      Designed by FallingBrick